Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Hepatobiliary & Pancreatic Diseases International : HBPD INT|September 17, 2022
Current and emerging immunotherapeutic approaches for biliary tract cancersZhen-Gang Yuan, Tian-Mei Zeng, Chen-Jie Tao
Journal of Hematology & Oncology|April 30, 2009
Treatment of multicentric Castleman's Disease accompanying multiple myeloma with bortezomib: a case reportZhen-gang Yuan, Xiao-yi Dun, Yong-hua Li, et al.
Leukemia & Lymphoma|October 30, 2009
Thyroid function and its clinical significance in POEMS syndromeXiao-Yi Dun, Fan Zhou, Hao Xi, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 11, 2008
[Study on the relationship of beta-catenin level and sensitivity to Bortezomib of myeloma cell lines]Li-Li Zhou, Wei-Jun Fu, Zhen-Gang Yuan, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|March 5, 2008
[Effect of arsenic trioxide combined with bortezomib on proliferation, apoptosis and beta-catenin level in myeloma cell lines]Li-Li Zhou, Wei-Jun Fu, Zhen-Gang Yuan, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|December 14, 2007
[Efficacy of thalidomide combined dexamethasone on newly diagnosed multiple myeloma]Zhen-Gang Yuan, Jian Hou, Dong-Xing Wang, et al.
Zhonghua Nei Ke Za Zhi|August 8, 2008
[Bortezomib-based combination therapy for relapsed or refractory multiple myeloma]Zhen-gang Yuan, Jian Hou, Dong-xing Wang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 15, 2006
[Prognostic analysis and assessment on the clinical staging systems of multiple myeloma--a report of 206 cases]Zhong-Fei Tao, Wei-Jun Fu, Yu-Bao Chen, et al.
Chinese Medical Journal|October 16, 2007
Prognostic factors and staging systems of multiple myeloma:Zhong-fei Tao, Wei-jun Fu, Zhen-gang Yuan, et al.
Pageof 4